We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Arthroscopic Debridement Ineffective in Patients with Knee Osteoarthritis

By HospiMedica staff writers
Posted on 11 Feb 2008
Arthroscopic debridement (AD) is not effective for reducing pain and improving function in patients with osteoarthritis (OA) of the knee, according to the results of a new study.

Researchers from Khon Kaen University (Khon Kaen, Thailand) searched the Cochrane Central Register of Controlled Trials (CENTRAL), Medline (1966 - 2006), Cinhal (1982 - 2006), Embase (1988 - 2006), and Web of Science (1900 - 2006), as well as the bibliographies, reference lists, and cited web sites of identified papers. More...
Selection criteria were randomized controlled trial or controlled clinical trial design; comparison of efficacy of AD versus another surgical procedure, including sham or placebo surgery and other nonsurgical interventions; and participants diagnosed with primary or secondary knee OA without other joint involvement or conditions requiring long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Pain relief and improved function of the knee were the primary endpoints.

The three randomized controlled trials included in the review enrolled 271 patients. The first trial comparing AD with lavage and sham surgery, and found there was no significant difference compared to lavage. However, when compared with sham surgery, outcomes for AD were worse at 2 weeks and not significantly different at two years. The second randomized controlled trial compared AD with arthroscopic washout and showed that AD significantly reduced knee pain at five years compared to washout. In the third randomized controlled trial there was no significant difference for AD compared to closed-needle lavage. The study was published online in the January 23, 2008, issue of the Cochrane Database of Systematic Reviews.

"There is 'gold' level evidence that AD has no benefit for undiscriminated OA,” concluded lead author Wiroon Laupattarakasem, M.D., and colleagues. "Observational studies have shown benefits for arthroscopic debridement on the osteoarthritic knee, but other recent studies have yielded conflicting results that suggest AD may not be effective.”

Knee OA begins with deterioration of the articular cartilage. Primary OA of nonspecific cause generally has slower progression versus secondary OA, which has a definite cause.
One treatment option for OA is AD, which involves irrigation to remove debris and mechanical shaving or removal of loose or misshapen parts of the joint.


Related Links:
Khon Kaen University

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.